Archive: 27/05/2013

Valeant to buy Bausch + Lomb for $8.7B (Update)

Canadian drugmaker Valeant Pharmaceuticals said Monday that it will pay $8.7 billion to buy Bausch + Lomb, one of the world's best-known makers of contact lenses, in a massive expansion of Valeant's smaller ophthalmology ...

S. Korea's plastic surgery fad goes extreme

South Korea's obsession with plastic surgery is moving on from standard eye and nose jobs to embrace a radical surgical procedure that requires months of often painful recovery.

No new H7N9 cases in China for second week

No new human cases of the deadly H7N9 bird flu strain were recorded in China for the second week in a row, national health authorities said Monday, suggesting the outbreak has slowed.

page 4 from 6